{"filing":{"accession_number":"0001828316-26-000043","cik":"0001828316","ticker":"PHAR","company_name":"Pharming Group N.V.","form":"6-K","filing_date":"2026-09-29","report_date":"2026-09-29","primary_document":"pharmingannouncesceotransi.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1828316/000182831626000043/pharmingannouncesceotransi.htm"},"events":[{"id":35570,"run_id":32769,"accession_number":"0001828316-26-000043","anchor_item_number":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Pharming announced that CEO Fabrice Chouraqui has stepped down as Chief Executive Officer and Executive Director effective immediately, following mutual agreement with the Board due to misalignment on strategic priorities. While interim co-CEOs were appointed, the principal disclosed action is the departure of the CEO, making this an exec_departure event. This is material as CEO transitions affect investor assessment of leadership continuity and strategic direction.","company_name":"Pharming Group N.V.","ticker":"PHAR","filing_date":"2026-09-29","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":39661,"accession_number":"0001828316-26-000043","item_number":null,"item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Pharming announced that CEO Fabrice Chouraqui has stepped down as Chief Executive Officer and Executive Director effective immediately, following mutual agreement with the Board due to misalignment on strategic priorities. While interim co-CEOs were appointed, the principal disclosed action is the departure of the CEO, making this an exec_departure event. This is material as CEO transitions affect investor assessment of leadership continuity and strategic direction.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-29T10:41:36.298228+00:00","company_name":"Pharming Group N.V.","ticker":"PHAR","filing_date":"2026-09-29"}]}